Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Topoisomerase II alpha anticorps (AA 1352-1493)

Cet anticorps anti-Topoisomerase II alpha Monoclonal Lapin (Clone TOP2A-6570R) (ABIN7127012) détecte spécifiquement Topoisomerase II alpha dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7127012
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant Topoisomerase II alpha anticorps (AA 1352-1493) (ABIN7127012)

Antigène

Voir toutes Topoisomerase II alpha (TOP2A) Anticorps
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 191
  • 85
  • 46
  • 9
  • 6
  • 3
  • 3
  • 3
  • 1
Humain

Hôte

  • 140
  • 52
Lapin

Clonalité

  • 99
  • 93
Monoclonal

Conjugué

  • 119
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Topoisomerase II alpha est non-conjugé

Application

  • 132
  • 91
  • 52
  • 52
  • 40
  • 23
  • 18
  • 9
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

TOP2A-6570R
  • Épitope

    • 29
    • 15
    • 14
    • 11
    • 10
    • 9
    • 8
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Fonction

    Recombinant Topoisomerase II alpha (Proliferation & Drug-Resistance Marker) Antibody

    Specificité

    The topoisomerase II-°™ isoform is a 170kDa nuclear protein and plays an important role in DNA synthesis and RNA transcription, as well as chromosomal segregation during mitosis. Topoisomerase II-°™ is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells, and has been shown to be over-expressed in many human cancers. Decreased expression of Topoisomerase II-°™ is the predominant mechanism of resistance to several chemotherapeutic agents.

    Réactivité croisée (Details)

    Human.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493) (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Indications d'application

    Known_Application: Western Blot (2-4 μg/mL), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or Jurkat cells. Human tonsil or esophagus.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Autre désignation

    TOP2A

    Sujet

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, Topoisomerase DNA II alpha 170 kDa, TP2A

    HeLa or Jurkat cells. Human tonsil or esophagus.

    Poids moléculaire

    170kDa

    ID gène

    7153, 156346

    UniProt

    P11388

    Pathways

    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!